Drug Index


Indication :

  • Multidrug resistant Tuberculosis

Dosing :

>12 years:
First 2 weeks 400 mg/day. Week 3-24: 200 mg 3 times/week.

Adverse Effect :

Nausea, arthralgia, headache, elevated transaminases, QT prolongation.

Hepatic Dose :

No dosage adjustments are recommended in mild to moderate hepatic impairment. Bedaquiline has not been studied in patients with severe hepatic impairment.
01/24/2024 19:07:24 Bedaquiline
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0